Package speff2trial. February 20, 2015

Similar documents
Package ORIClust. February 19, 2015

Package frailtyhl. February 19, 2015

Package p3state.msm. R topics documented: February 20, 2015

Package QualInt. February 19, 2015

Package HAP.ROR. R topics documented: February 19, 2015

Package StepReg. November 3, 2017

ivlewbel: Uses heteroscedasticity to estimate mismeasured and endogenous regressor models

Package seqdesign. April 27, Version 1.1 Date

Package CompareTests

Package appnn. R topics documented: July 12, 2015

Implementing double-robust estimators of causal effects

Comparison And Application Of Methods To Address Confounding By Indication In Non- Randomized Clinical Studies

Package citccmst. February 19, 2015

Analysis of Vaccine Effects on Post-Infection Endpoints Biostat 578A Lecture 3

Package AbsFilterGSEA

Package inctools. January 3, 2018

Package singlecase. April 19, 2009

Package mdsdt. March 12, 2016

Package ordibreadth. R topics documented: December 4, Type Package Title Ordinated Diet Breadth Version 1.0 Date Author James Fordyce

Package Actigraphy. R topics documented: January 15, Type Package Title Actigraphy Data Analysis Version 1.3.

Package xseq. R topics documented: September 11, 2015

Package inote. June 8, 2017

The SAS SUBTYPE Macro

Package xmeta. August 16, 2017

Package ICCbin. November 14, 2017

Logistic Regression and Bayesian Approaches in Modeling Acceptance of Male Circumcision in Pune, India

Benchmark Dose Modeling Cancer Models. Allen Davis, MSPH Jeff Gift, Ph.D. Jay Zhao, Ph.D. National Center for Environmental Assessment, U.S.

Package prognosticroc

Selection and Combination of Markers for Prediction

Midterm Exam ANSWERS Categorical Data Analysis, CHL5407H

Package nopaco. R topics documented: April 13, Type Package Title Non-Parametric Concordance Coefficient Version 1.0.

Package PELVIS. R topics documented: December 18, Type Package

Package tumgr. February 4, 2016

Evaluating health management programmes over time: application of propensity score-based weighting to longitudinal datajep_

Package influence.me

Package BCRA. April 25, 2018

Estimating average treatment effects from observational data using teffects

Abstract. Introduction A SIMULATION STUDY OF ESTIMATORS FOR RATES OF CHANGES IN LONGITUDINAL STUDIES WITH ATTRITION

Package propoverlap. R topics documented: February 20, Type Package

Package clust.bin.pair

Modern Regression Methods

Introducing a SAS macro for doubly robust estimation

Inverse Probability of Censoring Weighting for Selective Crossover in Oncology Clinical Trials.

Lecture 21. RNA-seq: Advanced analysis

Part 8 Logistic Regression

Package BUScorrect. September 16, 2018

Package mediation. September 18, 2009

Package ExactCIdiff. February 15, 2013

Selected Topics in Biostatistics Seminar Series. Missing Data. Sponsored by: Center For Clinical Investigation and Cleveland CTSC

Age (continuous) Gender (0=Male, 1=Female) SES (1=Low, 2=Medium, 3=High) Prior Victimization (0= Not Victimized, 1=Victimized)

Joseph W Hogan Brown University & AMPATH February 16, 2010

A macro of building predictive model in PROC LOGISTIC with AIC-optimal variable selection embedded in cross-validation

Supplementary Online Content

Package wally. May 25, Type Package

Daniel Boduszek University of Huddersfield

Application of Cox Regression in Modeling Survival Rate of Drug Abuse

cloglog link function to transform the (population) hazard probability into a continuous

Division of Biostatistics College of Public Health Qualifying Exam II Part I. 1-5 pm, June 7, 2013 Closed Book

List of Figures. List of Tables. Preface to the Second Edition. Preface to the First Edition

Package cssam. February 19, 2015

Use of GEEs in STATA

Chapter 17 Sensitivity Analysis and Model Validation

Package SAMURAI. February 19, 2015

Daniel Boduszek University of Huddersfield

LOGLINK Example #1. SUDAAN Statements and Results Illustrated. Input Data Set(s): EPIL.SAS7bdat ( Thall and Vail (1990)) Example.

Analysis of Environmental Data Conceptual Foundations: En viro n m e n tal Data

Chapter 3 Software Packages to Install How to Set Up Python Eclipse How to Set Up Eclipse... 42

Computer Age Statistical Inference. Algorithms, Evidence, and Data Science. BRADLEY EFRON Stanford University, California

MODEL SELECTION STRATEGIES. Tony Panzarella

PubH 7405: REGRESSION ANALYSIS. Propensity Score

SUPPLEMENTARY MATERIAL

Package longroc. November 20, 2017

Two-stage Methods to Implement and Analyze the Biomarker-guided Clinical Trail Designs in the Presence of Biomarker Misclassification

Supplementary Appendix

BIOL 458 BIOMETRY Lab 7 Multi-Factor ANOVA

Bias reduction with an adjustment for participants intent to dropout of a randomized controlled clinical trial

Review: Logistic regression, Gaussian naïve Bayes, linear regression, and their connections

Case-Cohort Approach to Assessing Immunological Correlates of Risk, With Application to Vax004. Biostat 578A: Lecture 11

Prediction Model For Risk Of Breast Cancer Considering Interaction Between The Risk Factors

Package sbpiper. April 20, 2018

Methods to control for confounding - Introduction & Overview - Nicolle M Gatto 18 February 2015

Supplementary Online Content

Package GANPAdata. February 19, 2015

EPI 200C Final, June 4 th, 2009 This exam includes 24 questions.

Package rvtdt. February 20, rvtdt... 1 rvtdt.example... 3 rvtdts... 3 TrendWeights Index 6. population control weighted rare-varaints TDT

Regression Discontinuity Analysis

Package noia. February 20, 2015

BIOSTATISTICAL METHODS

Syntax Menu Description Options Remarks and examples Stored results Methods and formulas References Also see

Biostatistics II

Lecture Outline. Biost 590: Statistical Consulting. Stages of Scientific Studies. Scientific Method

Worth the weight: Using Inverse Probability Weighted Cox Models in AIDS Research

What s New in SUDAAN 11

Chapter 13 Estimating the Modified Odds Ratio

1. Objective: analyzing CD4 counts data using GEE marginal model and random effects model. Demonstrate the analysis using SAS and STATA.

Step 3 Tutorial #3: Obtaining equations for scoring new cases in an advanced example with quadratic term

Fundamental Clinical Trial Design

Anumber of clinical trials have demonstrated

Package ClusteredMutations

Weight Adjustment Methods using Multilevel Propensity Models and Random Forests

Transcription:

Version 1.0.4 Date 2012-10-30 Package speff2trial February 20, 2015 Title Semiparametric efficient estimation for a two-sample treatment effect Author Michal Juraska <mjuraska@u.washington.edu>, with contributions from Peter B. Gilbert <pgilbert@scharp.org>, Xiaomin Lu <xlu2@phhp.ufl.edu>, Min Zhang <mzhangst@umich.edu>, Marie Davidian <davidian@stat.ncsu.edu>, and Anastasios A. Tsiatis <tsiatis@stat.ncsu.edu> Maintainer Michal Juraska <mjuraska@u.washington.edu> Depends R (>= 2.7.2), leaps, survival Description The package performs estimation and testing of the treatment effect in a 2-group randomized clinical trial with a quantitative, dichotomous, or right-censored time-to-event endpoint. The improves efficiency by leveraging baseline predictors of the endpoint. The inverse probability weighting technique of Robins, Rotnitzky, and Zhao (JASA, 1994) is used to provide unbiased estimation when the endpoint is missing at random. License GPL-2 LazyLoad yes LazyData yes Repository CRAN Date/Publication 2012-10-30 19:58:36 NeedsCompilation no R topics documented: ACTG175.......................................... 2 modsearch......................................... 3 speff............................................. 4 1

2 ACTG175 speffsurv.......................................... 8 summary.speff........................................ 10 summary.speffsurv..................................... 11 Index 13 ACTG175 AIDS Clinical Trials Group Study 175 Description Usage Format ACTG 175 was a randomized clinical trial to compare monotherapy with zidovudine or didanosine with combination therapy with zidovudine and didanosine or zidovudine and zalcitabine in adults infected with the human immunodeficiency virus type I whose CD4 T cell counts were between 200 and 500 per cubic millimeter. data(actg175) A data frame with 2139 observations on the following 27 variables: pidnum patient s ID number age age in years at baseline wtkg weight in kg at baseline hemo hemophilia (0=no, 1=yes) homo homosexual activity (0=no, 1=yes) drugs history of intravenous drug use (0=no, 1=yes) karnof Karnofsky score (on a scale of 0-100) oprior non-zidovudine antiretroviral therapy prior to initiation of study treatment (0=no, 1=yes) z30 zidovudine use in the 30 days prior to treatment initiation (0=no, 1=yes) zprior zidovudine use prior to treatment initiation (0=no, 1=yes) preanti number of days of previously received antiretroviral therapy race race (0=white, 1=non-white) gender gender (0=female, 1=male) str2 antiretroviral history (0=naive, 1=experienced) strat antiretroviral history stratification (1= antiretroviral naive, 2= > 1 but 52 weeks of prior antiretroviral therapy, 3= > 52 weeks ) symptom symptomatic indicator (0=asymptomatic, 1=symptomatic) treat treatment indicator (0=zidovudine only, 1=other therapies) offtrt indicator of off-treatment before 96±5 weeks (0=no,1=yes)

modsearch 3 Details cd40 CD4 T cell count at baseline cd420 CD4 T cell count at 20±5 weeks cd496 CD4 T cell count at 96±5 weeks (=NA if missing) r missing CD4 T cell count at 96±5 weeks (0=missing, 1=observed) cd80 CD8 T cell count at baseline cd820 CD8 T cell count at 20±5 weeks cens indicator of observing the event in days days number of days until the first occurrence of: (i) a decline in CD4 T cell count of at least 50 (ii) an event indicating progression to AIDS, or (iii) death. arms treatment arm (0=zidovudine, 1=zidovudine and didanosine, 2=zidovudine and zalcitabine, 3=didanosine). The variable days contains right-censored time-to-event observations. The data set includes the following post-randomization covariates: CD4 and CD8 T cell count at 20±5 weeks and the indicator of whether or not the patient was taken off-treatment before 96±5 weeks. References Hammer SM, et al. (1996), "A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter.", New England Journal of Medicine, 335:1081 1090. modsearch Internal function for speff() Description modsearch is used internally by speff to construct an optimal model for prediction of the study endpoint or estimation of the missingness mechanism. Usage modsearch(, x, y, endpoint,, optimal, force.in, nvmax) Arguments x y a object with the response on the left of the ~ operator, and the linear predictor on the right. a matrix of at least two predictors a response vector

4 speff endpoint optimal force.in nvmax a character string specifying the type of the response variable; possible values are "quantitative" or "dichotomous". a character string specifying the type of search technique used in the model selection procedure; possible values are "exhaustive", "forward", or "backward". specifies the optimization criterion for model selection; possible values are "cp" for Mallow s Cp, "bic" for BIC, and "rsq" for R-squared. a vector of indices to columns of the design matrix that should be included in each regression model. the maximum number of covariates considered for inclusion in a model. See Also speff speff Semiparametric efficient estimation and testing for a two-sample treatment effect with a quantitative or dichotomous endpoint Description speff conducts estimation and testing of the treatment effect in a 2-group randomized clinical trial with a quantitative or dichotomous endpoint. The is a special case of Robins, Rotnitzky, and Zhao (1994, JASA). It improves efficiency by leveraging baseline predictors of the endpoint. The uses inverse probability weighting to provide unbiased estimation when the endpoint is missing at random. Usage speff(, endpoint=c("quantitative", "dichotomous"), data, postrandom=null, force.in=null, nvmax=9, =c("exhaustive", "forward", "backward"), optimal=c("cp", "bic", "rsq"), trt.id, conf.level=0.95, missctrl=null, misstreat=null, endctrlpre=null, endtreatpre=null, endctrlpost=null, endtreatpost=null) Arguments a object with the response on the left of the ~ operator, and the linear predictor on the right. The linear predictor specifies baseline and postrandomization variables that are considered for inclusion by the automated procedure for selecting the best models predicting the endpoint, separately for each treatment group. Interactions and variable transformations might also be considered. If predicted values for the endpoint are entered explicitly by the user, the can be of the form response ~ 1.

speff 5 endpoint a character string specifying the type of the response variable. The option "quantitative" (default) classifies the response as quantitative, and the mean difference is the measure of the treatment effect, whereas "dichotomous" specifies a dichotomous response, and the log odds ratio is the measure of the treatment effect. Only the first character is necessary. data Details postrandom force.in nvmax optimal trt.id conf.level missctrl misstreat endctrlpre endtreatpre endctrlpost endtreatpost a data frame in which to interpret the variables named in the, postrandom, and trt.id. a character vector designating postrandomization covariates included in the (this argument allows to distinguish baseline from postrandomiation covariates). a vector of indices to columns of the design matrix that should be included in each regression model. the maximum number of covariates considered for inclusion in a model. The default is 9. specifies the type of search technique used in the model selection procedure carried out by the regsubsets function. "exhaustive" (default) performs the all-subsets selection, whereas "forward" and "backward" execute a forward or backward step-wise selection, respectively. specifies the optimization criterion for model selection. The default is "cp", Mallow s Cp, which is equivalent to AIC. The other options are "bic" for BIC and "rsq" for R-squared. a character string specifying the name of the treatment indicator which can be a character or a numeric vector. The control and treatment group is defined by the alphanumeric order of labels used in the treatment indicator. the confidence level to be used for confidence intervals reported by summary.speff. estimated probabilities of observing the endpoint based on pre- and postrandomization information in the control group estimated probabilities of observing the endpoint based on pre- and postrandomization information in the treatment group predicted values of the endpoint using baseline information in the control group only predicted values of the endpoint using baseline information in the treatment group only predicted values of the endpoint using baseline and postrandomization information in the control group predicted values of the endpoint using baseline and postrandomization information in the treatment group The treatment effect is represented by the mean difference or the log odds ratio for a quantitative or dichotomous endpoint, respectively. Estimates of the treatment effect that ignore baseline covariates (naive) are included in the output.

6 speff Value Using the automated model selection procedure performed by regsubsets, four optimal regression models are developed for the study endpoint. Initially, all baseline and postrandomization covariates specified in the are considered for inclusion by the model selection procedure carried out separately in each treatment group. The optimal models are used to construct predicted values of the endpoint. Subsequently, in each treatment group, another regression model is fitted that includes only baseline covariates that were selected in the previous optimization. Then predicted values of the endpoint are computed based on these models. If missingness occurs in the endpoint variable, the model selection procedure is additionally used to determine the optimal models for predicting whether a subject has an observed endpoint, separately in each treatment group. The function regsubsets conducts optimization of linear regression models only. The following modification in the model selection is adopted for a dichotomous variable: initially, a logistic regression model is fitted with all baseline and postrandomization covariates included in the. Subsequently, an optimal model is selected by using a weighted linear regression with weights from the last iteration of the IWLS algorithm. The optimal model is then refitted by logistic regression. Besides using the built-in model selection algorithms, the user has the option to explicitly enter predicted values of the endpoint as well as estimated probabilities of observing the endpoint if it is missing at random. speff returns an object of class "speff" which can be processed by summary.speff to obtain or print a summary of the results. An object of class "speff" is a list containing the following components: coef cov varbeta rsq endpoint postrandom predicted conf.level n a matrix with estimates of treatment-specific mean responses and the treatment effect. a list with components naive and speff, each storing the covariance matrix of the estimated treatment-specific mean responses. a numeric vector of variance estimates of the naive and semiparametric treatment effect estimates. a list with components control and treatment containing objects for the optimal selected regression models. Set to NULL if predicted values are entered explicitly. a numeric vector of the R-squared statistics for the optimal selected regression models predicting the study endpoint. Set to NULL if predicted values are entered by the user. "quantitative" for a quantitative and "dichotomous" for a dichotomous response. a character vector of postrandomization covariates considered for selection. a logical vector; if TRUE, the built-in model selection procedure was employed for prediction of the study endpoint in the control and treatment group, respectively. confidence level of the confidence intervals reported by summary.speff. search technique employed in the model selection procedure. number of subjects in each treatment group.

speff 7 References Robins JM, Rotnitzky A, Zhao LP. (1994), "Estimation of regression coefficients when some regressors are not always observed.", Journal of the American Statistical Association, 89:846 66. Tsiatis AA, Davidian M, Zhang M, Lu X. (2007), "Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: A principled yet flexible approach.", Statistics in Medicine, 27:4658 4677. Zhang M, Tsiatis AA, Davidian M. (2008), "Improving efficiency of inferences in randomized clinical trials using auxiliary covariates.", Biometrics, 64:707 715. Davidian M, Tsiatis AA, Leon S. (2005), "Semiparametric estimation of treatment effect in a pretest-posttest study with missing data.", Statistical Science, 20:261 301. Zhang M, Gilbert P. (2009), "Increasing the efficiency of prevential trials by incorporating baseline covariates.", manuscript. See Also summary.speff Examples str(actg175) ### treatment effect estimation with a quantitative endpoint missing ### at random fit1 <- speff(cd496 ~ age+wtkg+hemo+homo+drugs+karnof+oprior+preanti+ race+gender+str2+strat+symptom+cd40+cd420+cd80+cd820+offtrt, postrandom=c("cd420","cd820","offtrt"), data=actg175, trt.id="treat") ### fit2 adds quadratic effects of CD420 and CD820 and their ### two-way interaction fit2 <- speff(cd496 ~ age+wtkg+hemo+homo+drugs+karnof+oprior+preanti+ race+gender+str2+strat+symptom+cd40+cd420+i(cd420^2)+cd80+cd820+ I(cd820^2)+cd420:cd820+offtrt, postrandom=c("cd420","i(cd420^2)", "cd820","i(cd820^2)","cd420:cd820","offtrt"), data=actg175, trt.id="treat") ### fit3 uses R-squared as the optimization criterion fit3 <- speff(cd496 ~ age+wtkg+hemo+homo+drugs+karnof+oprior+preanti+ race+gender+str2+strat+symptom+cd40+cd420+cd80+cd820+offtrt, postrandom=c("cd420","cd820","offtrt"), data=actg175, trt.id="treat", optimal="rsq") ### a dichotomous response is created with missing values maintained ACTG175$cd496bin <- ifelse(actg175$cd496 > 250, 1, 0) ### treatment effect estimation with a dichotomous endpoint missing ### at random fit4 <- speff(cd496bin ~ age+wtkg+hemo+homo+drugs+karnof+oprior+preanti+ race+gender+str2+strat+symptom+cd40+cd420+cd80+cd820+offtrt, postrandom=c("cd420","cd820","offtrt"), data=actg175, trt.id="treat", endpoint="dichotomous")

8 speffsurv speffsurv Semiparametric efficient estimation and testing for a two-sample treatment effect with a right-censored time-to-event endpoint Description Usage speffsurv conducts estimation and testing of the treatment effect in a two-group randomized clinical trial with a right-censored time-to-event endpoint. It improves efficiency by leveraging baseline predictors of the endpoint. speffsurv(, data, force.in=null, nvmax=9, =c("exhaustive", "forward", "backward"), optimal=c("cp", "bic", "rsq"), trt.id, conf.level=0.95, fixed=false) Arguments data force.in nvmax optimal trt.id conf.level fixed a object with the response variable on the left of the ~ operator and the linear predictor on the right. The response is a survival object of class Surv. The linear predictor specifies baseline variables that are considered for inclusion by the automated procedure for selecting the best models predicting the endpoint. Interactions and variable transformations might also be considered. a data frame in which to interpret the variables named in the and trt.id. a vector of indices to columns of the design matrix that should be included in each regression model. the maximum number of covariates considered for inclusion in a model. The default is 9. specifies the type of search technique used in the model selection procedure carried out by the regsubsets function. "exhaustive" (default) performs the all-subsets selection, whereas "forward" and "backward" execute a forward or backward step-wise selection, respectively. specifies the optimization criterion for model selection. The default is "cp", Mallow s Cp, which is equivalent to AIC. The other options are "bic" for BIC and "rsq" for R-squared. a character string specifying the name of the treatment indicator which can be a character or a numeric vector. The control and treatment group is defined by the alphanumeric order of labels used in the treatment indicator. the confidence level to be used for confidence intervals reported by summary.speffsurv. logical value; if FALSE (default), automated selection procedure is used for predicting the endpoint. Otherwise, all baseline variables specified in the are used.

speffsurv 9 Details Value The treatment effect is represented by the (unadjusted) log hazard ratio for the treatment versus control group. The estimate of the treatment effect using the (unadjusted) proportional hazards model is included in the output. Using the automated model selection procedure performed by regsubsets, two optimal linear regression models are developed to characterize the influence function of an estimator that is more efficient than the maximum partial likelihood estimator. The "efficient" influence function is searched in the space of influence functions that determine all regular and asymptotically linear estimators for the treatment effect (for definitions see, for example, Tsiatis, 2006). The space of influence functions has three components: the estimation space that characterizes all regular and asymptotically linear estimators that do not use baseline covariates. The other two subspaces, the randomization and censoring space, use baseline covariates to improve the efficiency in the estimation of the treatment effect (Lu, 2008). The automated model selection procedure is used to identify functions in the randomization and censoring space that satisfy a prespecified optimality criterion and that lead to efficiency gain by using baseline predictors of the outcome. The user has the option to avoid the automated variable selection and, instead, use all variables specified in the for the estimation of the treatment effect. This is achieved by setting fixed=true. speffsurv does not allow missing values in the data. speffsurv returns an object of class "speffsurv" which can be processed by summary.speffsurv to obtain or print a summary of the results. An object of class "speffsurv" is a list containing the following components: beta varbeta fixed conf.level n a numeric vector with estimates of the treatment effect from the unadjusted proportional hazards model and the semiparametric efficient model using baseline covariates, respectively. a numeric vector of variance estimates for the treatment effect estimates in beta. a list with components rndspace and censspace containing objects for the optimal selected linear regression models that characterize the optimal elements in the randomization and censoring space, respectively. Set to NULL if fixed=true. a logical value; if TRUE, the efficient estimator utilizes all baseline covariates specified in the. Otherwise, the automated selection procedure is used to identify covariates that ensure optimality. confidence level of the confidence intervals reported by summary.speffsurv. search technique employed in the model selection procedure. number of subjects in each treatment group. References Lu X, Tsiatis AA. (2008), "Improving the efficiency of the log-rank test using auxiliary covariates.", Biometrika, 95:679 694. Tsiatis AA. (2006), Semiparametric Theory and Missing Data., New York: Springer.

10 summary.speff See Also summary.speffsurv Examples str(actg175) data <- na.omit(actg175[actg175$arms<=1 & ACTG175$gender==0,]) ### efficiency-improved estimation of log hazard ratio using ### baseline covariates fit1 <- speffsurv(surv(days,cens) ~ cd40+cd80+age+wtkg+drugs+karnof+z30+ preanti+symptom, data=data, trt.id="arms") ### fit2 coerces the use of all specified baseline covariates; ### automated selection procedure is skipped fit2 <- speffsurv(surv(days,cens) ~ cd40+cd80+age+wtkg+drugs+karnof+z30+ preanti+symptom, data=data, trt.id="arms", fixed=true) summary.speff Summarizing results for semiparametric efficient estimation and testing for a 2-sample treatment effect Description summary for an object of class "speff". Usage ## S3 for class speff summary(object,...) Arguments object an object of class "speff".... for other s. Details print.summary.speff prints a formatted summary of results. In the initial section, s for the optimal selected regression models are printed with pertaining R-squared statistics for each treatment group. Further, an inferential table is produced with point and interval estimates of the treatment effect, standard error estimates, and Wald test p-values using both the naive and covariateadjusted estimation s. At least five significant digits are printed.

summary.speffsurv 11 Value A list with the following components: tab rsq predicted inferential table for the treatment effect. search technique employed in the model selection procedure. a numeric vector of the R-squared statistics for the optimal selected regression models predicting the study endpoint. a list with components control and treatment containing objects for the optimal selected regression models. a logical vector; if TRUE, the built-in model selection procedure was employed for prediction of the study endpoint in the control and treatment group, respectively. See Also speff Examples ### from the example for speff : fit1 <- speff(cd496 ~ age+wtkg+hemo+homo+drugs+karnof+oprior+preanti+ race+gender+str2+strat+symptom+cd40+cd420+cd80+cd820+offtrt, postrandom=c("cd420","cd820","offtrt"), data=actg175, trt.id="treat") summary(fit1) summary.speffsurv Summarizing results for semiparametric efficient estimation and testing for a two-sample treatment effect with a right-censored time-toevent endpoint Description summary for an object of class "speffsurv". Usage ## S3 for class speffsurv summary(object,...) Arguments object an object of class "speffsurv".... for other s.

12 summary.speffsurv Details Value print.summary.speffsurv prints a formatted summary of results. In the initial section, rightsided s defining the optimal selected functions in the randomization and censoring space are printed. Further, an inferential table is generated with point and interval estimates of the log hazard ratio, standard error estimates, and Wald test p-values using both the proportional hazards and covariate-adjusted estimation s. At least five significant digits are printed. A list with the following components: tab fixed inferential table for the treatment effect. search technique employed in the model selection procedure. a list with components rndspace and censspace containing objects for the optimal selected linear regression models that characterize the optimal elements in the randomization and censoring space, respectively. Set to NULL if fixed=true. a logical value; if TRUE, the efficient estimator utilized all baseline covariates specified in the. Otherwise, the automated selection procedure was used to identify covariates that ensure optimality. See Also speffsurv Examples ### from the example for speffsurv : data <- na.omit(actg175[actg175$arms<=1 & ACTG175$gender==0,]) fit2 <- speffsurv(surv(days,cens) ~ cd40+cd80+age+wtkg+drugs+karnof+z30+ preanti+symptom, data=data, trt.id="arms", fixed=true) summary(fit2)

Index Topic datasets ACTG175, 2 ACTG175, 2 modsearch, 3 speff, 4, 4, 11 speffsurv, 8, 12 summary.speff, 5 7, 10 summary.speffsurv, 8 10, 11 13